Sun pharma

COMPANY REVIEW SESSION

PRESENTED BY-MONIKA LOHIA (D-54)

GROWING TOGETHER • Sun Pharmaceutical Industries Limited (

NSE: SUNPHARMA, BSE: 524715) is • An Indian multinational pharmaceutical

company headquartered in Mumbai. • Manufactures and sells pharmaceutical

formulations and active pharmaceutical ingredients (APIs) primarily in India and the United States.

OVERVIEW• Started as partnership firm by Mr. Dilip Shanghavi in

1983 in Vapi with just five products to treat psychiatry ailments.

• Cardiology products were introduced in 1987 followed by gastroenterology products in 1989.

• Today it is the largest chronic prescription company in India and a market leader in psychiatry, neurology, cardiology, orthopaedics, ophthalmology, gastroenterology and nephrology.

• The 2015 acquisition of Ranbaxy has made the company the largest pharma company in India

KEY PEOPLE

CREATING VALUE

LEADERSHIP IN KEY THERAPEUTIC AREAS

KEY ACQUISITIONS

KEY PERFORMANCE INDICATORS

SPENDING DISTRIBUTION (GEOGRAPHY WISE)

GLOBAL MANUFACTURING FOOTPRINTS

SHARE HOLDINGS

STOCK MARKET

BALANCE SHEET

PROFIT AND LOSS STATEMENT

FINANCIAL RATIOS

RECENT NEWS• March 8, 2016- Sun Pharma signs M S Dhoni

as Revital H brand ambassador• Feb 12, 2016- Sun Pharma Q3 net profit

surges over 3-fold to Rs 1,417 crore• Jan 29, 2016- Sun Pharmaceuticals to sell

some low priority Ranbaxy brands • Dec 19, 2015- U.S. FDA warns Sun Pharma

over standards at Halol plant (Gujrat)• Sep 1 2015- Sun Pharma completes

acquisition of GSK Australia opiates biz

CONCLUSIONSun pharmaceuticals is performing well financials show that the company has huge scope of growth.After acquiring Ranbaxy it has become 5th largest pharmaceutical company in the world.So it is recommended to invest in this company.

ANY QUESTIONS ?